Product Information

CETIRIZINE-PSE ER 5-120 MG TAB is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.5776 per EA under NDC 45802014762. Its NADAC has been published 328 times since May 13, 2020.

FDA first approved this application on Nov 16, 2018.

CETIRIZINE-PSE ER 5-120 MG TAB

Cetirizine hydrochloride, Pseudoephedrine hydrochloride
$0.5776per EA
OTC

Strength

5; 120 mg/1; mg/1

NDC

45802014762

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA210719

FDA Approved

11/16/2018

On Market Since

3/31/2020

Pharmacological Classes

Adrenergic alpha-Agonists
Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist
alpha-Adrenergic Agonist

Price Statistics

The NADAC for CETIRIZINE-PSE ER 5-120 MG TAB has been published 328 times since May 13, 2020, and over the history we have for it it has declined 14.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5776 per EA
All-time high$0.7274 (Apr 14, 2021)
All-time low$0.5313 (Nov 20, 2024)
52-week high$0.5956
52-week low$0.5617
Median price$0.5958
Average price$0.6013
Largest weekly change+18.9% (Mar 17, 2021)
Weeks tracked328
Tracking sinceMay 13, 2020

Price History

1W

-1.6%

1M

-1.6%

3M

-1.9%

6M

-1.9%

1Y

+2.4%

3Y

-2.9%

5Y

-11.8%

All

-14.3%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CETIRIZINE-PSE ER 5-120 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for CETIRIZINE-PSE ER 5-120 MG TAB, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.5776 per EA (NDC 45802014762), effective Aug 19, 2026.

How has the price of CETIRIZINE-PSE ER 5-120 MG TAB changed over time?

Over the history we have for it, the NADAC for CETIRIZINE-PSE ER 5-120 MG TAB has declined 14.3%. It has been tracked across 328 weekly CMS publications since May 13, 2020.

What are the highest and lowest recorded NADAC prices for CETIRIZINE-PSE ER 5-120 MG TAB?

Since May 13, 2020, the NADAC for CETIRIZINE-PSE ER 5-120 MG TAB has ranged from a low of $0.5313 (Nov 20, 2024) to a high of $0.7274 (Apr 14, 2021), with a median of $0.5958 per EA.

Are there cheaper alternatives to CETIRIZINE-PSE ER 5-120 MG TAB?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CETIRIZINE-PSE ER 5-120 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures CETIRIZINE-PSE ER 5-120 MG TAB?

CETIRIZINE-PSE ER 5-120 MG TAB (NDC 45802014762) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.